QuidelOrtho Future Growth
Future criteria checks 0/6
QuidelOrtho is forecast to grow earnings and revenue by 98.5% and 1.4% per annum respectively. EPS is expected to grow by 98.6% per annum. Return on equity is forecast to be 6.2% in 3 years.
Key information
98.5%
Earnings growth rate
98.6%
EPS growth rate
Medical Equipment earnings growth | 14.2% |
Revenue growth rate | 1.4% |
Future return on equity | 6.2% |
Analyst coverage | Good |
Last updated | 11 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,899 | -2 | 427 | 472 | 6 |
12/31/2025 | 2,776 | -98 | 423 | 426 | 7 |
12/31/2024 | 2,763 | -1,896 | 14 | 124 | 7 |
9/29/2024 | 2,818 | -1,867 | -97 | 100 | N/A |
6/30/2024 | 2,835 | -1,859 | -170 | 23 | N/A |
3/31/2024 | 2,863 | -1,765 | -119 | 91 | N/A |
12/31/2023 | 2,998 | -10 | 71 | 280 | N/A |
10/1/2023 | 3,122 | 13 | 147 | 369 | N/A |
7/2/2023 | 3,162 | 45 | 109 | 318 | N/A |
4/2/2023 | 3,110 | 118 | 389 | 573 | N/A |
1/1/2023 | 3,266 | 549 | 744 | 885 | N/A |
10/2/2022 | 3,036 | 810 | 926 | 1,037 | N/A |
7/3/2022 | 2,762 | 1,006 | 936 | 1,124 | N/A |
4/3/2022 | 2,326 | 1,006 | 484 | 721 | N/A |
1/2/2022 | 1,699 | 704 | 513 | 806 | N/A |
10/3/2021 | 1,871 | 883 | 634 | 924 | N/A |
7/4/2021 | 1,837 | 900 | 712 | 917 | N/A |
3/31/2021 | 1,862 | 948 | 1,017 | 1,154 | N/A |
1/3/2021 | 1,662 | 810 | 565 | 630 | N/A |
9/30/2020 | 1,005 | 371 | 194 | 238 | N/A |
6/30/2020 | 655 | 155 | 152 | 181 | N/A |
3/31/2020 | 562 | 88 | 135 | 163 | N/A |
12/31/2019 | 535 | 73 | 107 | 134 | N/A |
9/30/2019 | 515 | 75 | 102 | 130 | N/A |
6/30/2019 | 506 | 69 | 117 | 147 | N/A |
3/31/2019 | 501 | 65 | 102 | 133 | N/A |
12/31/2018 | 522 | 74 | 105 | 136 | N/A |
9/30/2018 | 505 | 37 | 77 | 104 | N/A |
6/30/2018 | 438 | 20 | N/A | 67 | N/A |
3/31/2018 | 373 | 12 | N/A | 34 | N/A |
12/31/2017 | 278 | -8 | N/A | 28 | N/A |
9/30/2017 | 216 | -5 | N/A | 33 | N/A |
6/30/2017 | 214 | 0 | N/A | 38 | N/A |
3/31/2017 | 215 | 4 | N/A | 49 | N/A |
12/31/2016 | 192 | -14 | N/A | 12 | N/A |
9/30/2016 | 189 | -12 | N/A | 11 | N/A |
6/30/2016 | 187 | -12 | N/A | 11 | N/A |
3/31/2016 | 183 | -14 | N/A | -3 | N/A |
12/31/2015 | 194 | -6 | N/A | 37 | N/A |
9/30/2015 | 206 | 1 | N/A | 38 | N/A |
6/30/2015 | 201 | -4 | N/A | 42 | N/A |
3/31/2015 | 197 | -2 | N/A | 45 | N/A |
12/31/2014 | 184 | -7 | N/A | 36 | N/A |
9/30/2014 | 169 | -13 | N/A | 19 | N/A |
6/30/2014 | 160 | -12 | N/A | 14 | N/A |
3/31/2014 | 158 | -6 | N/A | 13 | N/A |
12/31/2013 | 177 | 7 | N/A | 26 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: QL1A is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: QL1A is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: QL1A is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: QL1A's revenue (1.4% per year) is forecast to grow slower than the German market (5.6% per year).
High Growth Revenue: QL1A's revenue (1.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: QL1A's Return on Equity is forecast to be low in 3 years time (6.2%).